Nicer than needles: Insulin pills for diabetes finally in clinical trials

June 2, 2010

After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News.

C&EN Senior Correspondent Ann Thayer notes that drug manufacturers have tried for years to develop oral without much success. Insulin is a peptide hormone that people with currently take by injection to bring their blood sugar to within normal levels. But doing so requires uncomfortable, inconvenient injections that can make patients reluctant to use the drug frequently enough to adequately control their blood sugar. An oral form of insulin could help solve this problem. However, stomach acids and enzymes easily destroy insulin and other protein-based drugs. Scientists have had difficulty finding an effective way to eliminate this problem.

They've responded to this challenge by developing special coatings for insulin pills that prevent stomach acid from destroying them. Scientists also are using additives that make it easier for the intestine to absorb large molecules like insulin. After years of setbacks, signs of success may be at hand. Several insulin pills are now in various stages of , and proof of concept may allow them to move into late-stage and more rigorous clinical testing. Only time will tell, however, whether these much-anticipated will make it to the market.

Explore further: Insulin pill could replace injections for diabetes

More information: "Nicer Than Needles", pubs.acs.org/cen/coverstory/88/8822cover2.html

Related Stories

Insulin pill could replace injections for diabetes

April 28, 2008

Insulin pills to replace the injections necessary for those suffering from diabetes appear closer to reality through new research by chemical and biomedical engineers at The University of Texas at Austin.

Recommended for you

Hydrogen from sunlight—but as a dark reaction

December 9, 2016

The storage of photogenerated electric energy and its release on demand are still among the main obstacles in artificial photosynthesis. One of the most promising, recently identified photocatalytic new materials is inexpensive ...

Cloud formation—how feldspar acts as ice nucleus

December 9, 2016

In the atmosphere, feldspar particles act as ice nuclei that make ice crystals grow in clouds and enable precipitation. The discovery was made by researchers of Karlsruhe Institute of Technology (KIT) and University College ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.